Speech Accessibility Project starts recruitment of U.S. and Puerto Rican stroke survivors

The Speech Accessibility Project has begun recruiting U.S. and Puerto Rican adults who have had a stroke.

CellCentric receives FDA Fast Track designation for relapsed refractory multiple myeloma drug

CellCentric has announced that the U.S. Food and Drug Administration (FDA) has granted its novel cancer drug, inobrodib, Fast Track designation for the treatment of

June 13, 2023

Neurocrine culls Phase 2 neuropsych med after failing to validate earlier data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 14, 2024

What the U.S. election could mean for Medicare, drug pricing, and AI

BOSTON — There are huge stakes for health care in the upcoming U.S. election — and leaders from across the political spectrum weighed in on policy

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.